Letter to Editor

CXCR4: A Potential Biomarker for Targeted Cancer Therapy in the Future

Asieh Heirani-Tabasi

Asieh Heirani-Tabasi
Stem Cells and Regenerative Medicine Department, ACECR-Khorasan Razavi, Mashhad, Iran. Email: asieh.heirani@gmail.com
Online First: February 29, 2016 | Cite this Article
Heirani-Tabasi, A. 2016. CXCR4: A Potential Biomarker for Targeted Cancer Therapy in the Future. The Cancer Press 2(1): 23-24. DOI:10.15562/tcp.14


Cancer is known as the tsunami because it is the third leading cause of deaths in Iran. Almost all cancer cases have been diagnosed at the last stages and usually a patient loss the golden time due to the compatibility issues with chemo-therapy. Targeted therapy could be a gold standard therapeutic way to treat cancer at its best time.
No Supplementary Material available for this article.
Article Views      : 292
PDF Downloads : 99